Skip to Content
Merck

Angioedema complicating lisinopril therapy.

The Central African journal of medicine (1992-09-01)
M C Nzerue
ABSTRACT

A case of angioedema induced by antihypertensive therapy with lisinopril is presented. The patient was a 70 year old black woman, with a history of hypertension for 15 years. The patient presented with acute onset of swelling involving the oro-facial region and respiratory distress after ingestion of three doses of lisinopril over a three day period. A clinical diagnosis of drug induced angioedema was made based on clinical presentation. The patient was treated with diphenhydramine, 50 mg intravenously, and hydrocortisone 100 mg every eight hours with resolution of her symptoms over a 24 hour period. Angioedema should be recognized as a possible life threatening complication of therapy with lisinopril, and other angiotensin converting enzyme (ACE) inhibitors. This usually responds to therapy with antihistamines and steroids if recognized early.

MATERIALS
Product Number
Brand
Product Description

Supelco
Lisinopril, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Lisinopril, ≥98% (HPLC)
USP
Lisinopril, United States Pharmacopeia (USP) Reference Standard
Lisinopril dihydrate, European Pharmacopoeia (EP) Reference Standard